2017
DOI: 10.1016/j.urology.2016.09.042
|View full text |Cite
|
Sign up to set email alerts
|

Outcomes and Prognostic Factors of Primary Urethral Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
38
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 49 publications
(41 citation statements)
references
References 25 publications
3
38
0
Order By: Relevance
“…We show here that there were no significant differences in survival among patients with SCC, TCC, or Ac. Surprisingly, CSS was significantly worse for women with Ac, which is consistent with a study of 869 women with PUC11 and may be explained by differences in sex-specific anatomy, tumor biology, tumor location, positive lymph-node status, and marital status. Further, men with Ac experience longer survival,12 which supports our results.…”
Section: Discussionsupporting
confidence: 88%
See 2 more Smart Citations
“…We show here that there were no significant differences in survival among patients with SCC, TCC, or Ac. Surprisingly, CSS was significantly worse for women with Ac, which is consistent with a study of 869 women with PUC11 and may be explained by differences in sex-specific anatomy, tumor biology, tumor location, positive lymph-node status, and marital status. Further, men with Ac experience longer survival,12 which supports our results.…”
Section: Discussionsupporting
confidence: 88%
“…PUC is a relatively rare cancer that accounts for <1% of all malignancies,2 and there are certain differences between clinicopathological findings for women and men with PUC 24,11,12. Here, we utilized SEER data to investigate the differences in clinicopathological characteristics and survival between women and men, and we evaluated prognostic factors as well.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…PCU had been classified according to WHO as urothelial (UCC), squamous (SCC) and adenocarcinoma (AC) of either unspecified or enteric type, with the remaining being extremely rare clear cell and adenoid cystic carcinomas [13]. UCC is the most frequent PCU, but most of the described PCU present with mixed urothelial and squamous differentiation [3,14].…”
Section: Discussionmentioning
confidence: 99%
“…Most patients are diagnosed with advanced disease [2–6]. These tumours have an aggressive natural history, with reported 5‐year overall survival rates of 32–54% [2,3,7,8]. Patient and tumour characteristics associated with oncological outcome include sex, age, tumour location, stage and nodal status [2,3,5,9,10].…”
Section: Introductionmentioning
confidence: 99%